Nikolaos-Andreas Anastasopoulos1* and Chamzin Alexander2
1First Propaedeutic Department of Surgery, National and Kapodistrian University of
2Department of Surgery, “Hippokrateion” General Hospital of Athens, Greece
*Corresponding Author: Nikolaos-Andreas Anastasopoulos, First Propaedeutic Department of Surgery, National and Kapodistrian University of Athens, Greece.
Received: April 17, 2020; Published: April 30, 2020
Pilonidal disease is a common acquired condition due to the presence of loose hair in the natal cleft. Typically, it presents in younger male patients, and there is an assortment of therapeutic options, with a variable recurrence rate. We present the case of a 32-year old patient with recurrent pilonidal sinuses and abscesses, that came to our outpatient clinic for definitive treatment of his coccygeal disease. We performed a wide surgical excision with a Limberg flap reconstruction, and a negative pressure wound drain. The patient was discharged on the second postoperative pain, with minimal pain and the drain was removed three days after discharge. Sutures were removed on the twentieth postoperative day and follow-up was carried out once weekly for a monthly period. No wound dehiscence or flap necrosis were observed during the immediate follow-up period with a recurrence-free satisfactory aesthetic result, one year after the operation. In an era of numerous available techniques for treating pilonidal disease, the Limberg flap remains an easily reproducible and highly safe technique, even for surgeons with little or no experience regarding flap reconstruction surgery.
Keywords: Pilonidal Disease; Recurrence; Definitive Therapy; Limberg Flap
Citation: Nikolaos-Andreas Anastasopoulos and Chamzin Alexander. “Using a Limberg Flap to Treat Recurrent Pilonidal Disease: A Case Report with a Mini-Review”. Acta Scientific Clinical Case Reports 1.4 (2020): 16-21.
Copyright: © 2020 Nikolaos-Andreas Anastasopoulos and Chamzin Alexander. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.